As 2025 drew to a close, health officials across the United States noted a sharp uptick in the spread of respiratory illnesses, with data from the Centers for Disease Control and Prevention (CDC) indicating that COVID‑19, influenza, and respiratory syncytial virus (RSV) were circulating at increasingly high levels in many parts of the country. This rise in transmission came at a time when millions of Americans were traveling for the holidays and gathering indoors, conditions that have historically contributed to the spread of respiratory pathogens.
The CDC’s latest modeling of the time-varying reproductive number, or Rt, revealed that COVID-19 transmission was likely growing in most states as of late December, with Rt values exceeding the critical threshold of 1.0 across large portions of the country. An Rt above 1.0 suggests that each infected person is, on average, passing the virus to more than one other individual — a clear signal of expanding transmission. Similar trends were observed for influenza and RSV, both of which showed either stable or increasing transmission levels, depending on the region. These findings offer a snapshot of the broader respiratory virus landscape heading into 2026, marked by heightened viral activity and increasing pressures on healthcare systems.
Beyond these transmission estimates, the CDC also reported that emergency department visits for respiratory symptoms rose notably in December. Hospitalizations associated with influenza increased steadily throughout the month, and pediatric wards in many regions experienced a surge in RSV-related admissions, particularly among children under the age of five. COVID-19, while not reaching the peak hospitalization levels seen in previous pandemic waves, nonetheless showed signs of resurgence, with case counts and test positivity increasing week over week in many states.
The convergence of these three viruses — often referred to as a “tripledemic” — has become an increasingly familiar pattern during the winter months, and public health officials are warning that this season could be more intense than previous ones. Compared to the 2024–25 season, current trends suggest that viral activity began earlier and rose more quickly. Some experts attribute this shift to waning population immunity, decreased vaccine uptake, and continued viral evolution, particularly in influenza strains.
A major driver behind the current flu surge appears to be the prevalence of a fast-spreading influenza A (H3N2) variant, identified by researchers as subclade K. This strain has become dominant in several parts of the country and is responsible for a growing proportion of laboratory-confirmed flu cases. While early data do not indicate that the subclade causes more severe illness than other flu strains, its high transmissibility has led to a rapid increase in cases, hospitalizations, and pediatric deaths. Complicating matters is the fact that the current flu vaccine may not be optimally matched to this circulating strain, potentially limiting its effectiveness in preventing infection, although it still offers protection against severe disease.
COVID-19, though no longer dominating headlines to the same degree as during earlier stages of the pandemic, remains a significant contributor to respiratory illness burden. The CDC’s data show a gradual increase in transmission throughout December, with many localities reporting higher-than-expected case counts and test positivity. Hospitalizations have followed suit, especially among older adults and those with underlying conditions. While national mitigation measures have largely been scaled back, local health departments in some areas have issued advisories recommending masks in high-risk settings and urging residents to stay current on vaccinations.
RSV continues to pose a serious threat to infants and young children, with hospital emergency rooms in several states seeing a substantial rise in visits for bronchiolitis and other RSV-related complications. This pattern aligns with historical norms, as RSV typically peaks in late fall and early winter. However, this season’s intensity and early start have added further strain to pediatric healthcare resources, already stretched by co-circulating flu and COVID-19.
Healthcare providers across the country are responding to these developments by reallocating staff, opening surge capacity in emergency departments, and reminding the public of the importance of preventive measures. Medical professionals continue to advocate for the use of layered protection strategies, such as handwashing, masking in crowded indoor spaces, and isolating when symptomatic. While some of these practices have declined in public use since the peak of the COVID-19 pandemic, health officials stress that they remain highly effective in reducing transmission of all respiratory viruses.
Vaccination continues to be one of the most important tools in preventing severe illness. Yet, uptake of both influenza and COVID-19 vaccines has lagged behind public health targets in 2025, particularly among younger adults and some underserved communities. Efforts to close these gaps include expanded vaccine access in pharmacies, community health clinics, and school-based programs. Public awareness campaigns are also underway to highlight the benefits of vaccination and encourage individuals, especially those at higher risk, to take protective steps during the remainder of the respiratory season.
Looking ahead, public health officials are closely monitoring how these trends evolve as the country enters the early months of 2026. While respiratory illness activity often peaks in January or February, unpredictable viral dynamics and shifting population behavior could extend elevated transmission longer than expected. The CDC and its partners continue to analyze multiple data sources, including hospital admission rates, laboratory surveillance, and emergency department visits, to inform public health recommendations and resource planning.
In the face of elevated respiratory virus circulation, officials emphasize the importance of community-level awareness, timely vaccination, and preventive behaviors to reduce the burden on healthcare systems and protect vulnerable populations during what appears to be an intense and evolving respiratory virus season.
